CD52

Target id: 2602

Nomenclature: CD52

Family: CD molecules

Annotation status:  image of a grey circle Awaiting annotation/under development. Please contact us if you can help with annotation.  » Email us

   GtoImmuPdb view: OFF :     CD52 has curated GtoImmuPdb data

Gene and Protein Information
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 61 1p36 CD52 CD52 molecule
Mouse - 74 4 D3 Cd52 CD52 antigen
Rat - 96 5q36 Cd52 CD52 molecule
Previous and Unofficial Names
CAMPATH-1 antigen | myeloid cell surface antigen CD33
Database Links
ChEMBL Target
DrugBank Target
Ensembl Gene
Entrez Gene
GenitoUrinary Development Molecular Anatomy Project
Human Protein Atlas
KEGG Gene
OMIM
RefSeq Nucleotide
RefSeq Protein
UniProtKB
Wikipedia

Download all structure-activity data for this target as a CSV file

Antibodies
Key to terms and symbols Click column headers to sort
Antibody Sp. Action Affinity Units Reference
alemtuzumab Hs Binding - - 1-2
[1-2]
Immunopharmacology Comments
CD52 (CAMPATH-1) is a short, glycosylphosphatidylinositol (GPI) anchored peptide expressed on lymphocytes and by cells of the male genital tract. CD52 is required for complement-mediated cell lysis and antibody-mediated cellular cytotoxicity. The approved monoclonal antibody, alemtuzumab targets this function of CD52. By attaching to sperm it may be associated with oocyte penetration and fertilisation.
Immuno Cell Type Associations
Immuno Cell Type:  Macrophages & monocytes
Cell Ontology Term:   macrophage (CL:0000235)
monocyte (CL:0000576)
Comment: 
References: 
Immuno Cell Type:  Natural killer cells
Cell Ontology Term:  
Comment: 
References: 
Immuno Cell Type:  B cells
Cell Ontology Term:  
Comment: 
References: 
Immuno Cell Type:  T cells
Cell Ontology Term:  
Comment: 
References: 

References

Show »

1. Ginaldi L, De Martinis M, Matutes E, Farahat N, Morilla R, Dyer MJ, Catovsky D. (1998) Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H. Leuk. Res.22 (2): 185-91. [PMID:9593475]

2. Shitara K, Niwa R, Natsume A. (2011) Recombinant antibody composition. Patent number: US7923538 B2. Assignee: Kyowa Hakko Kirin Co., Ltd. Priority date: 22/07/2005. Publication date: 12/04/2011.

How to cite this page

CD molecules: CD52. Last modified on 06/02/2017. Accessed on 17/12/2017. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2602.